-
Mashup Score: 16Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients - 3 year(s) ago
Purpose of Review The role of renin-angiotensin-aldosterone system (RAAS) inhibitors, notably angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), in the COVID-19 pandemic has not been fully evaluated. With an increasing number of COVID-19 cases worldwide, it is imperative to better understand the impact of RAAS inhibitors in hypertensive COVID patients….
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 5Lipid Lowering Drugs: Present Status and Future Developments - 3 year(s) ago
Purpose of review Based on the recent data of the DA VINCI study, it is clear that, besides utilization of statins, there is a need to increase non-statin lipid lowering approaches to reduce the cardiovascular burden in patients at highest risk. Recent findings For hypercholesterolemia, the small synthetic molecule bempedoic acid has the added benefit of selective liver activation, whereas…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet-
RT @drpablocorral: 🙌 Lipid Lowering Drugs: Present Status and Future Developments https://t.co/0iOw7mtYsq https://t.co/jW3Y4pr86b
-
-
Mashup Score: 0Strengthening the Learning Health System in Cardiovascular Disease Prevention: Time to Leverage Big Data and Digital Solutions - 3 year(s) ago
Purpose of Review The past few decades have seen significant technologic innovation for the treatment and diagnosis of cardiovascular diseases. The subsequent growing complexity of modern medicine, however, is causing fundamental challenges in our healthcare system primarily in the spheres of patient involvement, data generation, and timely clinical implementation. The Institute of Medicine…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet-
Strengthening the Learning Health System in CVD Prevention: Time to Leverage Big Data and Digital Solutions Congrats to @Anjali_Wagle of the @OslerResidency for leading this article along with @hopkinsheart fellow @NinoIsakadze Collab w/ @khurramn1 https://t.co/cjvQbleWLi https://t.co/NhMntR8yjX
-
-
Mashup Score: 1
Purpose of the Review The purpose of this review is to analyze the evidence for use of mechanical circulatory support (MCS) with a focus on women, namely, intra-aortic balloon pump (IABP), Impella, ventricular assist devices (VAD), and extracorporeal membrane oxygenation (ECMO). Recent Findings There is paucity of data examining management options for cardiogenic shock (CS) in women specifically….
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet-
@mmamas1973 @MinnowWalsh @hvanspall @GarimaVSharmaMD @GiuseppeGalati_ @thaiscoutinhoCV @gina_lundberg @DrMarthaGulati @SharonneHayes @MihaiTrofenciuc @JJheart_doc @DrNasrien @cwhhs @MKIttlesonMD @ErinMichos @manalalasnag @agtruesdell 🗝only 33% of MCS recipients were ♀ w trend to even lower use over time 🗝 ♀have a ⬆️ risk profile eg ⬆️age, ⬆️ comorbidities, ⬆️ST, more ⬇️BP & index vasopressor requirement 🗝⬆️ bleeding & vasc complic & 30-day readmission https://t.co/Dnq4VYN21Z
-
-
Mashup Score: 0
Establishing a diagnosis of ischemic heart disease (IHD) in women, including assessment for coronary microvascular dysfunction (CMD) when indicated, can be challenging. Access to performance of invasive testing when appropriate may be limited, and noninvasive imaging assessments have evolved. This review will summarize the various noninvasive imaging modalities available for the diagnosis of IHD…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet-
JUST RELEASED: State of the art imaging in stable ischemic heart dz in 👩🦰 👉Covers full gamut of macro & microvascular dz 👉Role of #CVNuc 👉Role of #WhyCMR 👉 Role of #echofirst https://t.co/XTtwlnelLL Honored to coauthor with: @PriyaKoilpillai @HeartDocSharon https://t.co/r8Yfwa7ggA
-
-
Mashup Score: 2
The review highlights selected studies related to cardiovascular disease (CVD) prevention that were presented at the 2020 European Society of Cardiology (ESC) Congress—The Digital Experience. The studies reviewed include clinical trials on novel RNA interference-based lipid-lowering therapies AKCEA-APOCIII-LRx and vupanorsen (AKCEA-ANGPTL3-LRx); the EVAPORATE trial assessing the effects of…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet-
RT @jia_xiaoming: Our review recapping major prevention studies presented at ESC Congress 2020. https://t.co/dvQmQKlyJ4 @virani_md @AlizaHu…
-
-
Mashup Score: 6Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care - 4 year(s) ago
To highlight the gender-based differences in presentation and disparities in care for women with familial hypercholesterolemia (FH). Women with FH experience specific barriers to care including underrepresentation in research, significant underappreciation of risk, and interrupted therapy during childbearing. National and international registry and clinical trial data show significant healthcare…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet-
A2: Women with FH face specific challenges including planning for pregnancy, menopause. New publication highlights differences #KnowFH @sujana_balla @FaRodriguezMD @joshuaknowles @gina_lundberg @DrMarthaGulati https://t.co/EbgCGEHPWf https://t.co/6uKnw0wjZg
-
-
Mashup Score: 1Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients - 4 year(s) ago
The role of renin-angiotensin-aldosterone system (RAAS) inhibitors, notably angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), in the COVID-19 pandemic has not been fully evaluated. With an increasing number of COVID-19 cases worldwide, it is imperative to better understand the impact of RAAS inhibitors in hypertensive COVID patients. PubMed, Embase and the…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet-
yey! my interview with BBC East reached 100 likes! Thank you to all! The paper itself did exceptionally well with >700 outlets reporting on it, 22K downloads already- and the highest Altmetric score any of my papers, reaching 1507!!!! https://t.co/GKvyO8MaQ8 https://t.co/hkvelaWm3V
-
-
Mashup Score: 2Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients - 4 year(s) ago
The role of renin-angiotensin-aldosterone system (RAAS) inhibitors, notably angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), in the COVID-19 pandemic has not been fully evaluated. With an increasing number of COVID-19 cases worldwide, it is imperative to better understand the impact of RAAS inhibitors in hypertensive COVID patients. PubMed, Embase and the…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet-
Dear @UEAResearch @uniofeastanglia @UeaMed friends - have a look at Tweet ⬆️ You night see a familiar place & person! @SusanMadden18 @troeberg @SmithLabUEA @vcrodrigues_uea @GeneticsMBBS @CrichtonLab @KrisBowles7 @RushworthLab @VRMedicsNorwich @c_hellmich https://t.co/GKvyO8MaQ8
-
-
Mashup Score: 6Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients - 4 year(s) ago
The role of renin-angiotensin-aldosterone system (RAAS) inhibitors, notably angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), in the COVID-19 pandemic has not been fully evaluated. With an increasing number of COVID-19 cases worldwide, it is imperative to better understand the impact of RAAS inhibitors in hypertensive COVID patients. PubMed, Embase and the…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet-
Thank you @bbc East for the interview about our recent paper! Check at 37s!! A familiar beard-free me! ACEi/ARB safe in #covid - STAY ON THEM! https://t.co/GKvyO8MaQ8 @hvanspall @DrMarthaGulati @mirvatalasnag @AnastasiaSMihai @mmamas1973 @Hragy @purviparwani @ShrillaB @EkateriniL https://t.co/65YapfAYyH
-
Most downloaded from EJPC @m_piepoli Unsurprisingly ACE 2 in #Covid downloaded a lot!!! A topic close to my heart! #ESCPrev2021 DON'T STOP ACE/ARB! They are safe and could be helpful!! #epeeps #cardioed https://t.co/GKvyO8MaQ8 & https://t.co/gTQeckSQxo @BenSaaud @ShraboniGhosal https://t.co/anwajIPEgL